| answer text |
<p>On 24 February 2016, the National Institute for Health and Care Excellence published
a new best practice guideline on the assessment and management of Motor Neurone Disease
(MND). The guideline sets out the signs and symptoms of the disease and recommends
that robust protocols and pathways are in place to inform healthcare professionals
about MND, how it may present and to inform healthcare professionals in all settings
about local referral arrangements. The guideline can be found by following the link
below:</p><p><a href="http://www.nice.org.uk/guidance/ng42/resources/motor-neurone-disease-assessment-and-management-1837449470149"
target="_blank">www.nice.org.uk/guidance/ng42/resources/motor-neurone-disease-assessment-and-management-1837449470149</a></p><p>Further
to this, the Royal College of General Practitioners (RCGP) and the MND Association
have worked together to produce a ‘Red Flag Tool’ which sets out key signs of MND
to help general practitioners to identify suspected cases and refer them promptly
to a neurologist for appropriate investigation. The RCGP and the British Medical Journal
have both produced MND e-learning courses.</p>
|
|
